Production (Stage)
Aldeyra Therapeutics, Inc.
ALDX
$2.22
-$0.03-1.33%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 8.45% | -29.18% | -49.25% | -47.04% | -49.68% |
Total Receivables | -98.49% | -- | -- | -- | 210,870.46% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -3.41% | 35.47% | 40.05% | 28.97% | 15.10% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -80.30% | -50.45% | -7.40% | 44.40% | 188.16% |
Total Current Assets | -34.16% | -29.59% | -20.71% | -19.19% | -16.17% |
|
|||||
Total Current Assets | -34.16% | -29.59% | -20.71% | -19.19% | -16.17% |
Net Property, Plant & Equipment | 2.41% | -48.32% | 358.86% | 187.39% | 126.14% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -34.04% | -29.48% | -20.34% | -19.00% | -16.00% |
|
|||||
Total Accounts Payable | 23.47% | -86.51% | -24.39% | -6.06% | -34.77% |
Total Accrued Expenses | 29.27% | 118.88% | 32.89% | -37.24% | -58.82% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -98.35% | -98.03% | -95.98% | 157.26% | 1,250.08% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -34.10% | -16.44% | -20.65% | 76.83% | 35.41% |
|
|||||
Total Current Liabilities | -34.10% | -16.44% | -20.65% | 76.83% | 35.41% |
Long-Term Debt | -- | -- | 464.50% | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 3.30% | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 6.15% | 17.77% | 32.75% | 7.77% | -9.99% |
|
|||||
Common Stock & APIC | 1.53% | 1.37% | 1.33% | 1.23% | 1.21% |
Retained Earnings | -14.34% | -14.17% | -11.50% | -9.93% | -8.06% |
Treasury Stock & Other | 153.33% | -- | -- | -- | -- |
Total Common Equity | -43.93% | -40.73% | -30.82% | -24.31% | -17.36% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -43.93% | -40.73% | -30.82% | -24.31% | -17.36% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -43.93% | -40.73% | -30.82% | -24.31% | -17.36% |
|